Anorexia Nervosa, Restricting Type
11
2
2
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (11)
Biomarkers in EV Associated With Marrow Adiposity in Anorexia
CGM in Patients With ED's
Novel Targetable BIOmarkers in ANorexia NervosA
Fecal Microbiota Transplant for Anorexia Nervosa
Acetylcholinesterase Inhibitor in Anorexia Nervosa: Multicenter, Double-Blind, Placebo-Controlled Trial
A Multi-Site Study of MDMA-Assisted Psychotherapy for Eating Disorders
Adaptive Treatment for Adolescent Anorexia Nervosa
Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa
Anxiety and Reward Interaction and Prediction of Outcomes in Anorexia Nervosa
Project CORE: Disseminating Eating Disorders Treatment
Effects of a High Intensity Resistance Training in Muscular Strength, Agility, and Body Composition of Anorexia Nervosa Restricting Type Patients